Amplitude Healthcare Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to focus on the life sciences and pharmaceutical services sectors in the United States and Europe. Amplitude Healthcare Acquisition Corporation was incorporated in 2019 and is based in New York, New York.
IPO Year: 1991
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
Fastest customizable press release news feed in the world
Combined company expected to begin trading on the Nasdaq Global Select Market under "JSPR" and "JSPRW" on or about September 27, 2021 Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the completion of its business combination with Amplitude Healthcare Acquisition Corporation (NASDAQ:AMHC), a special purpose acquisition company sponsored by affiliates of Avego Management, LLC and Metalmark Capital. The business combination closed on September 24, 2021. Following the closing, the combined company will operate as Jasper Therapeutics, Inc. and, on or about September 27, 2021, its shares of voting common stock and warrants ar
Exhibit 99.1 REDWOOD CITY, Calif. and NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Amplitude Healthcare Acquisition Corporation (NASDAQ:AMHC) ("AMHC"), a special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the "Business Combination") with Jasper Therapeutics, Inc. ("Jasper"), a biotechnology company focused on the development of novel curative therapies based on the biology of the hematopoietic stem cell, and all other proposals presented at AMHC''s special shareholder's meeting held on September 22, 2021. AMHC''s shareholders approved the Business Combination proposal with 74.9% votes in favor of the
8-K/A - Amplitude Healthcare Acquisition Corp (0001788028) (Filer)
8-K - Amplitude Healthcare Acquisition Corp (0001788028) (Filer)
25-NSE - Amplitude Healthcare Acquisition Corp (0001788028) (Subject)
8-K - Amplitude Healthcare Acquisition Corp (0001788028) (Filer)
425 - Amplitude Healthcare Acquisition Corp (0001788028) (Subject)
8-K - Amplitude Healthcare Acquisition Corp (0001788028) (Filer)
425 - Amplitude Healthcare Acquisition Corp (0001788028) (Subject)
8-K - Amplitude Healthcare Acquisition Corp (0001788028) (Filer)
425 - Amplitude Healthcare Acquisition Corp (0001788028) (Subject)
EFFECT - Amplitude Healthcare Acquisition Corp (0001788028) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G - Jasper Therapeutics, Inc. (0001788028) (Subject)
SC 13D - Jasper Therapeutics, Inc. (0001788028) (Subject)
SC 13G - Jasper Therapeutics, Inc. (0001788028) (Subject)
SC 13G - Jasper Therapeutics, Inc. (0001788028) (Subject)
SC 13G - Jasper Therapeutics, Inc. (0001788028) (Subject)
SC 13G - Jasper Therapeutics, Inc. (0001788028) (Subject)
SC 13G - Jasper Therapeutics, Inc. (0001788028) (Subject)
SC 13G - Amplitude Healthcare Acquisition Corp (0001788028) (Subject)
SC 13G/A - Amplitude Healthcare Acquisition Corp (0001788028) (Subject)
SC 13G/A - Amplitude Healthcare Acquisition Corp (0001788028) (Subject)